AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21864370 — intervention group
Group type: COMPARATOR
Intervention: TAU only
Number of subjects: 340
Study 21864370 — intervention group
Group type: EXPERIMENTAL
Intervention: PEPS therapy plus TAU
Number of subjects: 340
Study 20046538 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening, brief intervention and referral to treatment (SBIRT)
Number of subjects: 0
Study 17084787 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy
Number of subjects: 0
Study 17084787 — intervention group
Group type: COMPARATOR
Intervention: Cognitive‐Behavioral Coping Skills Therapy
Number of subjects: 0
Study 17084787 — intervention group
Group type: COMPARATOR
Intervention: Twelve‐Step Facilitation Therapy
Number of subjects: 0
Study 15605326 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Rehabilitation and Prevention Program (CRPP) - an 8-week exercise and education class in phase 2
Number of subjects: 269
Study 15605326 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy without exercise program (control group)
Number of subjects: 269
Study 15605326 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost utility of CRPP
Number of subjects: 269
Study 11287029 — intervention group
Group type: EXPERIMENTAL
Intervention: DMPA+E(2)C injection on day 7 of the menstrual cycle (delayed-injection group, n = 117)
Number of subjects: 158
Study 11287029 — intervention group
Group type: COMPARATOR
Intervention: DMPA+E(2)C injection on day 5 of the menstrual cycle (control group, n = 41)
Number of subjects: 158
Study 9311402 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis (audio tape daily 4-6 days prior to surgery)
Number of subjects: 50
Study 9311402 — intervention group
Group type: COMPARATOR
Intervention: Control (no hypnosis)
Number of subjects: 50
Study 9311402 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 50
Study 9311402 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 50
Study 8455803 — intervention group
Group type: EXPERIMENTAL
Intervention: Marine fish-oil supplements rich in n-3 fatty acids
Number of subjects: 0
Study 8455803 — intervention group
Group type: EXPERIMENTAL
Intervention: Marine fish-oil supplements
Number of subjects: 0
Study 3510017 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse home visitation during pregnancy
Number of subjects: 0
Study 3510017 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no nurse home visitation)
Number of subjects: 0
Study 31738792 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program (20 sessions over 10 weeks) targeting gait and balance, delivered by physiotherapists.
Number of subjects: 223
Study 28461168 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced communication skills training
Number of subjects: 27425
Study 28461168 — intervention group
Group type: COMPARATOR
Intervention: Untrained sites
Number of subjects: 27425
Study 25739829 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (375 mg/m²/week for 4 weeks) with glucocorticoids and two intravenous cyclophosphamide pulses
Number of subjects: 44
Study 25739829 — intervention group
Group type: COMPARATOR
Intervention: Intravenous cyclophosphamide for 3-6 months followed by azathioprine with glucocorticoids (Control group)
Number of subjects: 44
Study 25739829 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab group
Number of subjects: 44
Study 25739829 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study 22706617 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine transdermal patch (5 μg/h)
Number of subjects: 37
Study 22167031 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ketamine (10 mg in 20 ml of fruit juice)
Number of subjects: 36
Study 22167031 — intervention group
Group type: COMPARATOR
Intervention: Placebo (20 ml of fruit juice)
Number of subjects: 36
Study 18379339 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 25
Study 17000358 — intervention group
Group type: EXPERIMENTAL
Intervention: Myocardial contrast echocardiography (MCE)
Number of subjects: 51
Study 17000358 — intervention group
Group type: COMPARATOR
Intervention: Technetium‐99m sestamibi single photon emission computed tomography (SPECT)‐myocardial perfusion imaging (MPI)
Number of subjects: 51
Study 12855084 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive virtual reality (IVR) sessions of V-Store
Number of subjects: 0
Study 12855084 — intervention group
Group type: COMPARATOR
Intervention: Non-immersive (flat screen) sessions of V-Store
Number of subjects: 0
Study 11059522 — intervention group
Group type: EXPERIMENTAL
Intervention: Buteyko Breathing Technique (BBT)
Number of subjects: 36
Study 11059522 — intervention group
Group type: COMPARATOR
Intervention: Placebo video
Number of subjects: 36
Study 10901839 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobazam (30 mg daily)
Number of subjects: 128
Study 10901839 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (3 mg daily)
Number of subjects: 128
Study 10901839 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (30 mg daily)
Number of subjects: 128
Study 10901839 — intervention group
Group type: COMPARATOR
Intervention: Placebo (after abrupt withdrawal of clobazam, lorazepam, or buspirone)
Number of subjects: 128
Study 1511768 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly constructed information leaflet
Number of subjects: 144
Study 1511768 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling interview
Number of subjects: 144
Study 1511768 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical intervention (colposcopy examination or outpatient ablative treatment)
Number of subjects: 144
Study 6140167 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid (5-AS) 0.5 g suppositories
Number of subjects: 15
Study 6140167 — intervention group
Group type: COMPARATOR
Intervention: Sulphasalazine (SZ) 1 g tid (equivalent to 5-AS 1.14 g/day)
Number of subjects: 15
Study 6140167 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral slow-release form of 5-AS
Number of subjects: 15
Study 6140167 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-AS and AcAS
Number of subjects: 15
Study 31360062 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (50,000 IU once a week for 8 weeks, then once a month for 4 months)
Number of subjects: 63
Study 31360062 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 28968171 — intervention group
Group type: EXPERIMENTAL
Intervention: Naldemedine 0.2 mg
Number of subjects: 193
Study 28968171 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study 25720723 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavonoids (Group A)
Number of subjects: 59
Study 25720723 — intervention group
Group type: COMPARATOR
Intervention: Control (Group B)
Number of subjects: 59
Study 23203345 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative visual conditioning stimuli (pictures)
Number of subjects: 31
Study 23203345 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral visual conditioning stimuli (pictures)
Number of subjects: 31
Study 23203345 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive visual conditioning stimuli (pictures)
Number of subjects: 31
Study 23203345 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweet gustatory stimuli (gelatine)
Number of subjects: 31
Study 23203345 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitter gustatory stimuli (gelatine)
Number of subjects: 31
Study 23203345 — intervention group
Group type: COMPARATOR
Intervention: Thermal stimuli (control experiment)
Number of subjects: 31
Study 21632737 — intervention group
Group type: EXPERIMENTAL
Intervention: Online coaching support from a certified peer specialist
Number of subjects: 118
Study 21632737 — intervention group
Group type: COMPARATOR
Intervention: No online coaching support (Control)
Number of subjects: 118
Study 19336559 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplementation
Number of subjects: 388
Study 19336559 — intervention group
Group type: COMPARATOR
Intervention: Control (no folic acid supplementation)
Number of subjects: 388
Study 19336559 — intervention group
Group type: EXPERIMENTAL
Intervention: Right colon
Number of subjects: 388
Study 19336559 — intervention group
Group type: EXPERIMENTAL
Intervention: Left colon
Number of subjects: 388
Study 19336559 — intervention group
Group type: EXPERIMENTAL
Intervention: LINE-1 methylation
Number of subjects: 388
Study 16923481 — intervention group
Group type: EXPERIMENTAL
Intervention: Active patch (GTN)
Number of subjects: 318
Study 16923481 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 318
Study 15504999 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced therapy (handheld infrared skin thermometer, measuring temperatures on the sole of the foot in the morning and evening)
Number of subjects: 85
Study 15504999 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (therapeutic footwear, diabetic foot education, regular foot evaluation by a podiatrist)
Number of subjects: 85
Study 12243704 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing (HCD) over clobetasol propionate 0.05% lotion once a week
Number of subjects: 61
Study 12243704 — intervention group
Group type: COMPARATOR
Intervention: Clobetasol propionate ointment used unoccluded twice a day
Number of subjects: 61
Study 8327414 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive behavioral program for smoking cessation
Number of subjects: 3923
Study 8327414 — intervention group
Group type: COMPARATOR
Intervention: Aerosol inhaler (active bronchodilator or placebo)
Number of subjects: 3923
Study 8327414 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum as an adjunct to the behavioral program
Number of subjects: 3923
Study 3526421 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 0
Study 3526421 — intervention group
Group type: COMPARATOR
Intervention: Domperidone
Number of subjects: 0
Study 31021112 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who purchased items for others (intervention group)
Number of subjects: 437
Study 31021112 — intervention group
Group type: COMPARATOR
Intervention: Participants who purchased items for themselves (control group)
Number of subjects: 437
Study 31021112 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual differences in OXTR single nucleotide polymorphisms (rs53576, rs2268498, rs2254298)
Number of subjects: 437
Study 29175065 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteal phase support starting 1 day after oocyte retrieval (group A)
Number of subjects: 233
Study 29175065 — intervention group
Group type: COMPARATOR
Intervention: Luteal phase support on the day of oocyte retrieval (group B)
Number of subjects: 233
Study 27099249 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean diet (MedDiet) interventions
Number of subjects: 751
Study 27099249 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline short- and medium-chain acylcarnitines
Number of subjects: 751
Study 27099249 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased short-chain acylcarnitines after 1 year
Number of subjects: 751
Study 24468997 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based care delivered by trained lay workers
Number of subjects: 1453
Study 24468997 — intervention group
Group type: COMPARATOR
Intervention: Clinic-based care
Number of subjects: 1453
Study 21951265 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 24
Study 21951265 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 20679146 — intervention group
Group type: EXPERIMENTAL
Intervention: Barley beta-glucan-enriched biscuits (BB), 628 kJ preload
Number of subjects: 20
Study 20679146 — intervention group
Group type: COMPARATOR
Intervention: Control biscuits (CB), 628 kJ preload
Number of subjects: 20
Study 20679146 — intervention group
Group type: EXPERIMENTAL
Intervention: Barley beta-glucan-enriched biscuits (BB), 1884 kJ preload
Number of subjects: 20
Study 20679146 — intervention group
Group type: COMPARATOR
Intervention: Control biscuits (CB), 1884 kJ preload
Number of subjects: 20
Study 19374071 — intervention group
Group type: EXPERIMENTAL
Intervention: African potato (AP) decoction administered daily from day 16 to day 30
Number of subjects: 10
Study 15754421 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 31
Study 15754421 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 31
Study 15754421 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 12719963 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritionally-sourced tryptophan (1.8 g)
Number of subjects: 24
Study 12719963 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 10320169 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.04 mg/kg) IV
Number of subjects: 30
Study 10320169 — intervention group
Group type: COMPARATOR
Intervention: Placebo IV
Number of subjects: 30
Study 8943160 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine
Number of subjects: 584
Study 8943160 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 584
Study 1285937 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 67
Study 1285937 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 2859792 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise intervention
Number of subjects: 59
Study 2859792 — intervention group
Group type: COMPARATOR
Intervention: Control group (similar patients not receiving exercise intervention)
Number of subjects: 59
Study 29742525 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 700
Study 29668535 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly high-dose oral cholecalciferol over 2 years
Number of subjects: 4
Study 27567760 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal Vibrations (FV)
Number of subjects: 20
Study 27567760 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 20
Study 25320235 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological inhibition of PCSK9
Number of subjects: 0
Study 25320235 — intervention group
Group type: EXPERIMENTAL
Intervention: PCSK9 loss-of-function genetic variants
Number of subjects: 0
Study 25320235 — intervention group
Group type: COMPARATOR
Intervention: LPS administration
Number of subjects: 0
Study 25320235 — intervention group
Group type: COMPARATOR
Intervention: PCSK9 function
Number of subjects: 0
Study 22782510 — intervention group
Group type: EXPERIMENTAL
Intervention: ADNI
Number of subjects: 0
Study 22782510 — intervention group
Group type: COMPARATOR
Intervention: MCSA
Number of subjects: 0
Study 20171404 — intervention group
Group type: COMPARATOR
Intervention: Placebo effects
Number of subjects: 0
Study 20171404 — intervention group
Group type: COMPARATOR
Intervention: Placebo effects in clinical practice
Number of subjects: 0
Study 18330460 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT), 8 sessions
Number of subjects: 39
Study 15839956 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-platinum combination therapy
Number of subjects: 802
Study 15839956 — intervention group
Group type: COMPARATOR
Intervention: Conventional platinum-based therapy
Number of subjects: 802
Study 12209102 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment with HDM-impermeable encasings for mattresses, pillows, and duvets for 12 months.
Number of subjects: 86
Study 12209102 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment with cotton encasings for mattresses, pillows, and duvets for 12 months.
Number of subjects: 86
Study 12209102 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (active and placebo)
Number of subjects: 86
Study 10496190 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydralazine plus isosorbide dinitrate (H‐I) in black patients
Number of subjects: 180
Study 10496190 — intervention group
Group type: COMPARATOR
Intervention: Enalapril therapy in white patients
Number of subjects: 180
Study 10496190 — intervention group
Group type: COMPARATOR
Intervention: Enalapril therapy in white patients with a history of hypertension
Number of subjects: 180
Study 10496190 — intervention group
Group type: COMPARATOR
Intervention: Placebo group in V‐HeFT I
Number of subjects: 180
Study 10496190 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitalization rates
Number of subjects: 180
Study 9191512 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 2 mg
Number of subjects: 260
Study 9191512 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 4 mg
Number of subjects: 260
Study 9191512 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 8 mg
Number of subjects: 260
Study 9191512 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 16 mg
Number of subjects: 260
Study 9191512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260
Study 1511219 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 30
Study 1511219 — intervention group
Group type: EXPERIMENTAL
Intervention: CT
Number of subjects: 30
Study 1511219 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiography
Number of subjects: 30
Study 1511219 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI and CT combined
Number of subjects: 30
Study 1511219 — intervention group
Group type: EXPERIMENTAL
Intervention: MR-angiography
Number of subjects: 30
Study 6587296 — intervention group
Group type: EXPERIMENTAL
Intervention: Zomepirac sodium 100 mg
Number of subjects: 117
Study 6587296 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoprofen calcium 200 mg
Number of subjects: 117
Study 6587296 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 30882751 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 1 × 200 mg elemental iron (SINGLE)
Number of subjects: 24
Study 30882751 — intervention group
Group type: COMPARATOR
Intervention: Split dose of 2 × 100 mg elemental iron (SPLIT)
Number of subjects: 24
Study 30882751 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study 30300426 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% saline
Number of subjects: 40
Study 30300426 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 40
Study 27553102 — intervention group
Group type: EXPERIMENTAL
Intervention: Right bundle branch block (RBBB)
Number of subjects: 682
Study 27553102 — intervention group
Group type: EXPERIMENTAL
Intervention: Left bundle branch block (LBBB)
Number of subjects: 682
Study 27553102 — intervention group
Group type: COMPARATOR
Intervention: No bundle branch block (no-BBB)
Number of subjects: 682
Study 27553102 — intervention group
Group type: EXPERIMENTAL
Intervention: RBBB
Number of subjects: 682
Study 27553102 — intervention group
Group type: EXPERIMENTAL
Intervention: LBBB
Number of subjects: 682
Study 25272316 — intervention group
Group type: EXPERIMENTAL
Intervention: Early goal-directed therapy (EGDT)
Number of subjects: 1600
Study 25272316 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1600
Study 22712470 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin microsphere gel 0.04% pump
Number of subjects: 110
Study 22712470 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 110
Study 20096223 — intervention group
Group type: EXPERIMENTAL
Intervention: TIVA with remifentanil
Number of subjects: 70
Study 20096223 — intervention group
Group type: COMPARATOR
Intervention: Balanced anesthesia (BA) with esmolol
Number of subjects: 70
Study 20096223 — intervention group
Group type: EXPERIMENTAL
Intervention: TIVA with remifentanil and BA with esmolol
Number of subjects: 70
Study 17636093 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exercise with bright light treatment
Number of subjects: 25
Study 17636093 — intervention group
Group type: COMPARATOR
Intervention: Moderate exercise without bright light treatment
Number of subjects: 25
Study 16118756 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip head-conserving therapy with two cranial screws and a three-point-supported screw at Adam's arc
Number of subjects: 0
Study 16118756 — intervention group
Group type: COMPARATOR
Intervention: Conventional osteosynthesis
Number of subjects: 0
Study 11900101 — intervention group
Group type: EXPERIMENTAL
Intervention: Geometric prototypes located at the centers of left and right categories
Number of subjects: 0
Study 11900101 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsets of targets positioned at different locations within each category
Number of subjects: 0
Study 10084466 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide turbuhaler, 1,600 microg
Number of subjects: 10
Study 10084466 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 10084466 — intervention group
Group type: COMPARATOR
Intervention: Formoterol + Placebo
Number of subjects: 10
Study 10084466 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol + Budesonide
Number of subjects: 10
Study 7567130 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 1,000 mg intravenously 30 min before anesthesia
Number of subjects: 20
Study 7567130 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 1,000 mg intravenously before anesthesia and a second 1,000 mg dose at the initiation of cardiopulmonary bypass
Number of subjects: 20
Study 7567130 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (1,000 mg and 2,000 mg regimens)
Number of subjects: 20
Study 2127604 — intervention group
Group type: EXPERIMENTAL
Intervention: hMG treatment with short-term GnRH agonist (Buserelin)
Number of subjects: 0
Study 2127604 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment with hMG alone
Number of subjects: 0
Study 2127604 — intervention group
Group type: EXPERIMENTAL
Intervention: hMG treatment started shortly after LH rise caused by GnRH agonist
Number of subjects: 0
Study 2127604 — intervention group
Group type: EXPERIMENTAL
Intervention: hMG treatment commenced when hypogonadotropic state achieved after long treatment of Buserelin
Number of subjects: 0
Study 2127604 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (hMG with and without GnRH agonist)
Number of subjects: 0
Study 2127604 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term group
Number of subjects: 0
Study 2127604 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term group
Number of subjects: 0